PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close
PhionX has pursued an asset overhaul centered on domestic real estate acquisition amid four straight years of revenue decline and continued losses, while repeated governance controversies involving asset transfers and management-rights deals tied to its controlling shareholders persist.
Annual revenue fell for four consecutive years, from KRW 68.9bn in 2022 to KRW 6.0bn in 2025.
In the most recent quarter (Q2 2026), revenue rose to KRW 2.49bn from prior lows, and the net loss narrowed.
The company changed its name from Ameridge Corporation to PhionX in May 2026.
In July 2026 the company formalized an asset-restructuring strategy to sell non-core overseas assets and use the proceeds to acquire real estate in Gwacheon, Gyeonggi Province.
Governance controversies—including alleged asset transfers to entities tied to the controlling shareholder, alleged falsified board resolutions, and alleged auditor collusion in CB transactions—have repeatedly surfaced.
PhionX (900100) is a Los Angeles-based holding company listed on KOSDAQ as a foreign issuer; it changed its name from New Pride Corporation to Ameridge Corporation, and then to PhionX in May 2026.
The industry tag on Korea's disclosure channel lists the company under 'automotive parts and interior goods sales,' which differs from the business areas the company actually describes.
The company has stated that it operates a fashion retail business running 'Papaya' women's apparel stores across nine US states, a wellness (cannabis) business that cultivates and processes cannabis for online and mobile delivery, and a real estate operation.
The cannabis-related business drew market attention at one point around a planned acquisition of a cultivation facility and announced production plans within the year.
In July 2026 the company formalized an asset-restructuring strategy to sequentially sell non-core assets and overseas real estate with low direct relevance to its business, using the proceeds to acquire real estate in Gwacheon, Gyeonggi Province.
Lux Hoover LLC, previously the largest shareholder, saw its share count fall sharply after a June 2026 share consolidation, with its stake reported at 13%.
In October 2025, an extraordinary shareholders' meeting was announced for Bogyeong Housing Construction-affiliated parties to acquire management rights without a control premium, and among the new director candidates was a figure linked to Intromedic, a company that received a delisting decision.
Throughout this process, governance controversies repeatedly surfaced, including circumstances suggesting the company-owned building was transferred to an entity affiliated with the controlling shareholder and used as loan collateral; the company has denied these allegations as groundless.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩1.8B | -₩1.9B | −101.3% |
| 2025Q3 | ₩1B | -₩1.9B | −187.8% |
| 2025Q4 | ₩900M | -₩900M | −105.7% |
| 2026Q1 | ₩1.2B | -₩1.1B | −89.1% |
| 2026Q2 | ₩2.5B | -₩1.1B | −45.2% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩68.9B | ₩1.3B | ₩1.4B | 1.9% | 2.0% | 13.0% |
| 2023 | ₩39.7B | -₩10.2B | -₩36.7B | −25.6% | −78.6% | 6.1% |
| 2024 | ₩18.8B | -₩11.3B | -₩15.8B | −60.3% | −43.2% | 22.3% |
| 2025 | ₩6B | -₩7.9B | -₩11.2B | −131.8% | −33.2% | 22.0% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-05
Annual revenue fell sharply for four straight years, from KRW 68.9bn in 2022 to KRW 39.7bn in 2023, KRW 18.8bn in 2024, and KRW 6.0bn in 2025.
Operating profit was positive at KRW 1.3bn in 2022 but turned negative for three consecutive years from 2023, with the 2025 operating loss (KRW 7.9bn) exceeding that year's revenue of KRW 6.0bn.
Net income attributable to owners swung from a KRW 1.4bn profit in 2022 to a KRW 36.7bn loss in 2023, before narrowing to a KRW 15.8bn loss in 2024 and an KRW 11.2bn loss in 2025.
Looking at the most recent four quarters (Q3 2025 through Q2 2026), revenue fell to KRW 1.0bn in Q3 2025 and KRW 0.9bn in Q4 2025 before rebounding to KRW 1.24bn in Q1 2026 and KRW 2.49bn in Q2 2026.
Over the same period, the net loss attributable to owners narrowed from KRW 4.65bn in Q2 2025 to KRW 2.21bn in Q3, KRW 1.34bn in Q4, KRW 1.14bn in Q1 2026, and KRW 1.14bn in Q2 2026.
Quarterly operating losses also eased somewhat, from around KRW 1.9bn to a range of roughly KRW 0.9bn to KRW 1.1bn, though the loss-to-revenue ratio remains high.
Total equity fell by more than half over four years, from KRW 72.8bn in 2022 to KRW 33.8bn in 2025, reflecting the cumulative erosion of capital by ongoing net losses.
The debt ratio has stayed low, at 6.1% in 2023 and 22.0% in 2025, suggesting the losses stem from weak operations and asset impairment rather than excessive borrowing.
Operating cash flow was positive at KRW 4.4bn in 2022 but turned negative in three of the following four years (-KRW 3.6bn in 2023, -KRW 9.0bn in 2024, -KRW 4.8bn in 2025), with the size of the outflow easing somewhat after 2024.
PhionX is a foreign issuer assigned a 900-series KOSDAQ ticker code; while it is classified under an automotive-related industry category in disclosures, its actual businesses span US fashion retail, cannabis, and real estate, making conventional industry comparisons difficult.
The group of so-called marginal companies to which it is often compared shares common traits: repeated changes of controlling shareholder, acquisitions of management rights without a control premium, and recurring fundraising via convertible bonds.
Indeed, one of the new director candidates was linked to Intromedic, a company that received a delisting decision in 2026 after its trading was suspended in 2021. Similarly, other small-cap KOSDAQ names have reportedly concentrated funds raised after a change of controlling shareholder into real estate purchases.
The cannabis business drew thematic attention at times, linked to expectations of relaxed medical and recreational cannabis regulation in parts of the United States. The fashion retail segment has not shown clear growth momentum amid structural stagnation in US brick-and-mortar retail.
The domestic real estate (Gwacheon) acquisition the company is pursuing appears to be more about asset reallocation than a genuine new business venture, with low direct relevance to the traditional auto parts or finished-vehicle industry cycle.
In July 2026 the company formalized an asset-restructuring strategy that sells non-core and overseas assets sequentially and channels the proceeds into acquiring real estate in Gwacheon, Gyeonggi Province.
The Gwacheon property was presented by the company as a strategic base where it expects asset value to rise, citing transport infrastructure and development demand.
The company said it plans to concentrate the liquidity raised on improving its financial structure, securing a foundation for new businesses, and expanding tangible assets.
However, the specific assets to be sold, counterparties, and acquisition timing have not yet been confirmed in disclosures, so the pace and actual scale of execution remain to be seen.
On the governance side, a transfer of management rights to parties affiliated with Bogyeong Housing Construction was announced in October 2025, followed by a reconstitution of the board and a reassessment of business direction.
The company has denied allegations such as asset misappropriation as having followed legal procedures, while also signaling a possible pivot toward new businesses such as bio and healthcare.
With legal proceedings including an injunction against new share listings still ongoing, the outcome of litigation and any changes in the shareholding structure remain variables that could affect future fundraising and management stability.
Having posted net losses for four consecutive years, the company is in a position where standard profit-based valuation metrics are difficult to apply meaningfully.
Its shares trade at a level below net asset value, which may suggest the market is weighting business sustainability and governance uncertainty more heavily than accounting-based asset value. With no dividend payment history, comparisons based on dividend yield also carry limited meaning.
Given the company's history of frequent rights offerings, convertible bond issuances, and repeated changes of bond subscribers, the possibility of future share dilution remains a variable that could affect assessments of asset value.
If the ongoing asset restructuring increases the share of tangible assets such as domestic real estate, the composition and quality of shareholders' equity could change, and this progress warrants continued monitoring.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-05
Among the most recent four quarters, Q2 2026 revenue climbed to KRW 2.49bn, notably up from the prior low of KRW 0.9bn in Q4 2025. Over the same period, the net loss attributable to owners narrowed from KRW 4.65bn in Q2 2025 to about KRW 1.14bn in Q2 2026.
Quarterly operating losses also eased from roughly KRW 1.9bn to about KRW 1.1bn. This suggests the loss structure may have passed a trough and entered a somewhat improving phase.
The debt ratio has stayed very low, in the 6% to 22% range between 2022 and 2025, suggesting the deterioration in results stems from shrinking revenue and asset impairment rather than excessive borrowing.
Low leverage could relatively widen the company's capacity to raise funds for future asset restructuring or new-business investment.
The company has stated it is pursuing the acquisition of domestic real estate, including in Gwacheon, using proceeds from the sale of non-core and overseas assets.
This represents an attempt to shift the asset mix from relatively opaque overseas holdings to comparatively transparent domestic tangible assets, which, if executed as planned, could contribute to improved asset quality.
Annual revenue fell to less than one-tenth of its former level, from KRW 68.9bn in 2022 to KRW 6.0bn in 2025, while operating profit turned from a gain to a loss that eventually exceeded revenue in size. This points to a structural weakening of the competitiveness of the company's existing core businesses.
A series of governance controversies has surfaced, including circumstances suggesting a company-owned building was transferred to an entity affiliated with the controlling shareholder and used as loan collateral, allegations of copy-pasted board signatures, and allegations of collusion with the external auditor in CB transactions.
In 2025, allegations of investment fraud also arose after the company reportedly failed to honor a memorandum of understanding on a management-rights acquisition with a private equity fund and instead pursued a third-party rights offering. The company has denied these allegations, but the recurrence of such controversies itself remains a burden.
The company has changed its name multiple times, from New Pride Corporation to Ameridge Corporation and then to PhionX, and its controlling shareholder has also shifted frequently, with a transfer from Lux Hoover LLC to parties affiliated with Bogyeong Housing Construction announced. This history can undermine market confidence in the company's business identity and management stability.
Numerous governance controversies have been reported, including alleged asset transfers to entities affiliated with the controlling shareholder, alleged falsified board disclosures, and alleged collusion with the external auditor related to CB transactions.
Related litigation, including an injunction against new share listings, is also ongoing, leaving legal uncertainty. The company has disputed the allegations, but confirming the facts may take time.
There is a gap between the disclosed industry classification and the businesses actually operated (fashion, cannabis, real estate), and revenue has fallen sharply for four consecutive years, raising questions about business sustainability.
If the planned asset restructuring does not proceed as intended, concerns over further deterioration in results or capital erosion could grow.
The company has a history of multiple rights offerings and convertible bond issuances with repeated changes of subscribers, and similar future fundraising could dilute existing shareholders.
A reverse share consolidation that has already occurred also makes it harder to track historical changes in share count going forward.
The filing deadline for the Q3 2026 (July-September) quarterly report arrives. It will be a point to check whether the recent revenue rebound and narrowing losses continue, and whether the asset restructuring affects reported earnings.
It is worth watching whether specific contract terms for the Gwacheon real estate acquisition and the non-core/overseas asset sales announced in July 2026 are disclosed.
The outcome of ongoing litigation, including the injunction against new share listings, and any follow-up disclosures on changes in controlling shareholder or management should be checked.
The FY2026 audit report and audit opinion are expected to be disclosed. Given the company's past history of a disclaimer of opinion, whether it maintains an unqualified opinion is directly tied to listing eligibility.
PhionX is a Los Angeles-headquartered foreign issuer operating fashion retail, cannabis, and real estate businesses, with a gap between its disclosed industry classification (automotive-related) and its actual business activities.
Revenue fell for four consecutive years, from KRW 68.9bn in 2022 to KRW 6.0bn in 2025, and while operating and net losses have persisted, the most recent quarter (Q2 2026) showed both a revenue rebound and a narrowing of losses.
The company has maintained a low debt ratio, but cumulative losses have cut shareholders' equity by more than half over four years.
At the same time, recurring governance controversies—including alleged asset transfers tied to the controlling shareholder, alleged falsified board disclosures, alleged collusion in CB transactions, and a disputed breakdown of a management-rights acquisition MOU—have surfaced, which the company has denied while presenting an asset-restructuring strategy centered on domestic real estate acquisition.
Going forward, the concrete execution of the asset restructuring, the outcome of ongoing litigation, and the durability of quarterly earnings improvement will likely be key variables shaping the company's direction. Continued monitoring of related disclosures and litigation developments is warranted.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.